Tech • AI • Robotics
50 articles analyzed by AI / 114 total
DeepHealth received FDA clearance in 2023 for its AI-powered breast ultrasound technology, enhancing breast cancer detection capabilities in medical imaging. This regulatory approval is a key milestone for AI adoption in diagnostic radiology.
Hackensack Meridian Health became the first U.S. health system to earn certification from The Joint Commission for responsible AI use in healthcare systems in 2023. This certification marks a major advancement in establishing ethical and safe AI practices in health services.
AI systems are being developed to detect diseases by analyzing sound patterns, enabling early diagnosis particularly for neurological and other health conditions. This innovative approach represents progress in non-invasive, AI-driven medical diagnostics.
Cigna reported strong Q2 2023 results with increased use of AI, more healthcare customers, and higher profits, reflecting AI’s growing role in insurance and health service operations. AI integration contributed significantly to the company's financial growth.
RecovryAI completed the patient phase of a pivotal clinical trial for its AI diagnostic tool in 2023, preparing for FDA De Novo submission. This progress signifies an important step towards regulatory approval of AI-driven clinical diagnostics.
A novel AI framework has been developed to enable collaboration between generalist and specialist AI models, improving disease diagnosis accuracy. This advancement could enhance the effectiveness of AI healthcare applications by combining broad and specialized expertise.
An Australian AI-powered medical scribe has been successfully adopted by Canadian doctors by 2023, illustrating growing acceptance of AI tools in healthcare documentation. This adoption highlights AI’s expanding role in administrative medical tasks.
An AI system has demonstrated the ability to predict cardiovascular disease specifically in women, focusing on targeted early diagnosis and risk assessment. This AI innovation addresses gender-specific health issues with improved predictive accuracy.
Ensora Health launched Ensai℠, an AI platform that supports five therapy disciplines in mental health treatment. This platform represents a significant advancement in AI applications for diverse therapeutic interventions.
Tempus AI acquired Personalis for $1.7 billion in 2023, aiming to enhance its digital health and AI-driven diagnostic and genomic data analysis services. This major acquisition underlines growing investments in AI for precision medicine.